Carr

$ACAD chart update post-$BIIB

看多
NASDAQ:ACAD   ACADIA Pharmaceuticals Inc.
1
The $BIIB buyout story has put a bid under other key biotech buyout targets like $ACAD. Chart shows a steady accumulation within a bullish channel in a modest uptrend.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。